Elevated expression of CD44 has been observed in various cancers such as prostate cancer, ovarian cancer, gallbladder cancer, oral squamous cell carcinoma and gastric cancer, demonstrating correlation with malignant biological phenotypes and an unfavorable prognosis [32, 33]. This evidence concerns the gene CD44 and oral cavity squamous cell carcinoma.